Literature DB >> 6969932

HLA B27, sacro-iliitis and peripheral arthropathy in acute anterior uveitis.

P Møoller, O Vinje, E G Olsen.   

Abstract

Thirty-four consecutively admitted patients with acute anterior uveitis (AAU) were examined. The male to female ratio was 1.8:1. Twenty-two patients (67%) were HLA B27 positive. Twelve (36%) had radiographical sacro-iliitis; all were males and were HLA B27 positive. Three of them were asymptomatic. Eighteen patients (53%) had low back pain suggestive of sacro-iliitis, but this symptom was associated neither with radiographical sacro-iliitis nor with HLA B27. Radiographical sacro-iliitis and HLA B27 occurred together more frequently in males than in females. It was concluded that the association between AAU and signs of joint affection reflects the association seen in HLA B27 positive patients, while HLA B27 negative patients suffered from low back pain as well. HLA B27 positive patients with AAU should be remitted for radiographical examination of the sacro-iliac joints.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969932     DOI: 10.3109/03009748009112354

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  4 in total

1.  Acute anterior uveitis, arthritides and enteric antigens.

Authors:  E Szanto; K Granfors; B Wretlind
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

Review 2.  B27 positive diseases versus B27 negative diseases.

Authors:  A Linssen; T E Feltkamp
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

3.  Acute anterior uveitis, ankylosing spondylitis, back pain, and HLA-B27.

Authors:  A B Beckingsale; J Davies; J M Gibson; A R Rosenthal
Journal:  Br J Ophthalmol       Date:  1984-10       Impact factor: 4.638

4.  The use of HLA-B27 as a diagnostic and prognostic aid in acute anterior uveitis (AAU) in The Netherlands.

Authors:  A Linssen; A J Dekker-Saeys; P F Dijkstra; A Rothova; P J Kruit; M Bakker; A Kijlstra; T E Feltkamp
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.